Mesalazine Oral Suspension in Active Eosinophilic Esophagitis
Clinical trial NCT05488405 · COMPLETED
Trial details
- NCT number
- NCT05488405
- Sponsor
- Dr. Falk Pharma GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-09
- Primary completion
- 2023-06-30
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.